Cardlytics, Inc.
For the period ended Nov 5, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 5, 2026 · Filed Nov 5, 2026
CDLX$1.95-11.0%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (Amounts in thousands, except par value amounts)
(Amounts in thousands, except par value amounts)
| September 30, 2026 | December 31, 2025 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $29,947 | $48,719 |
| Accounts receivable and contract assets, net | 59,891 | 82,458 |
| Other receivables | 2,479 | 2,474 |
| Prepaid expenses and other assets | 4,157 | 3,213 |
| Current assets of discontinued operations | — | 415 |
| Total current assets | 96,474 | 137,279 |
| Long-term assets: | ||
| Property and equipment, net | 1,478 | 1,931 |
| Right-of-use assets under operating leases, net | 3,786 | 4,723 |
| Goodwill | 110,305 | 110,305 |
| Capitalized software development costs, net | 15,303 | 19,005 |
| Other long-term assets, net | 1,169 | 1,235 |
| Noncurrent assets of discontinued operations | — | 11,163 |
| Total assets | $228,515 | $285,641 |
| Liabilities and stockholders' deficit | ||
| Current liabilities: | ||
| Accounts payable | $2,857 | $2,655 |
| Accrued compensation | 4,015 | 6,038 |
| Accrued expenses | 6,959 | 7,125 |
| Partner Share liability | 14,250 | 24,792 |
| Consumer Incentive liability | 21,603 | 32,144 |
| Deferred revenue and other liabilities | 2,048 | 2,541 |
| Current operating lease liabilities | 1,305 | 1,438 |
| Current liabilities of discontinued operations | — | 1,657 |
| Total current liabilities | 53,037 | 78,390 |
| Long-term liabilities: | ||
| Convertible senior notes, net | $169,692 | $168,850 |
| Lines of credit | 25,000 | 40,070 |
| Long-term operating lease liabilities | 3,810 | 4,748 |
| Long-term liabilities of discontinued operations | — | 91 |
| Total liabilities | $251,539 | $292,149 |
| Stockholders’ deficit: | ||
| Common stock, $0.0001 par value—10,000 shares authorized and 5,922 and 5,451 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively. | $1 | $1 |
| Additional paid-in capital | 1,410,330 | 1,399,551 |
| Accumulated other comprehensive loss | (988) | (1,996) |
| Accumulated deficit | (1,432,367) | (1,404,064) |
| Total stockholders’ deficit | (23,024) | (6,508) |
| Total liabilities and stockholders’ deficit | $228,515 | $285,641 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.